Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] LEENO Industrial (058470) – Reference Price Notice (Stock Split) / 2025-04-24

Posted on April 24, 2025August 4, 2026 By K-STOCK Editor No Comments on [Disclosure] LEENO Industrial (058470) – Reference Price Notice (Stock Split) / 2025-04-24

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

LEENO Industrial has announced a new reference price of KRW 34,500 for its common stock, effective April 25, 2025, following a stock split (par value KRW 500 to KRW 100).

📊 [Key Disclosure Details & Financial Figures]

  • Company Name: LEENO Industrial Inc.
  • Reference Price Details:
    • Security Type: Common Stock
    • Ticker Code: A058470
    • Reference Price: KRW 34,500
  • Effective Date: April 25, 2025
  • Reason: Stock split (Par value reduction from KRW 500 to KRW 100 per share)
  • Governing Provision: Article 17 of the Enforcement Rules of KOSDAQ Market Business Regulations

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Prior Stock Split Disclosures and KRX Announcements

The company has notified the reference price (KRW 34,500) and effective date (April 25, 2025) for its common stock resulting from the stock split (par value KRW 500 to KRW 100). Detailed terms and schedules regarding the stock split can be cross-checked in the prior ‘Decision on Stock Split’ disclosure filed on DART and official notices from the Korea Exchange (KRX).

📢 Disclaimer and Source Information

Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Notice: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific security. All investment decisions and financial responsibilities rest entirely with the individual investor.

Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2025-04-24
Next Post: [Disclosure] LEENO Industrial (058470) – Modification Listing (Change in Par Value) (Stock Split) / 2025-04-24

Related Posts

[Disclosure] Hana Micron (067310) – (Correction) Exercise of Conversion Right / 2024-03-15 Semiconductors
[Disclosure] Hanwha Systems (272210) Subsidiary HS USA Holdings Decision on KRW 84.63B Capital Increase for Acquisition of Securities Disclosures
[Disclosure] Hanwha Ocean (042660) – (Correction) Execution of Sales / Supply Contract / 2026-03-31 Disclosures
[Disclosure] Samsung Biologics (207940) – Single Sales and Supply Contract (Voluntary Disclosure) / 2025-12-22 Disclosures
[Disclosure] Hanwha Aerospace (012450) to Host Investor Relations (IR) Event for Domestic and Overseas Institutional Investors in Seoul on May 19, 2025 Disclosures
[Disclosure] Hana Micron (067310) – Additional Listing (Conversion of Domestic Private CB) / 2024-12-20 Semiconductors

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme